Dorsey Wright & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Dorsey Wright & Associates's MRK Position: Q2 2026 in Review
Dorsey Wright & Associates reduced its Merck (MRK) stake by 75% in Q2 2026, selling an estimated $979K and leaving 2,862 shares worth $368K. The position accounts for 0.06% of the portfolio, ranked #112.
Dorsey Wright & Associates first reported a position in MRK in Q2 2023 and has held it in 5 quarters since. The position peaked at $1.35M in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Dorsey Wright & Associates held 2,862 shares of Merck worth $368K as of Q2 2026.
- Dorsey Wright & Associates sold 8,363 Merck shares in Q2 2026, an estimated $979K.
- Merck made up 0.06% of Dorsey Wright & Associates's portfolio in Q2 2026, its #112 holding.
- Dorsey Wright & Associates first reported a position in Merck in Q2 2023 and has held it in 5 quarters since.
- Dorsey Wright & Associates's Merck position peaked at $1.35M in Q1 2026.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.